ICON Public Limited Company (ICLR) – Accellacare to Improve customer service

Evergreen Therapeutics, Inc. announced a clinical service agreement with ICON plc in Jun – 21. The agreement aims to conduct a global, multi center Phase II clinical trial for Evergreen’s COVID 19 drug therapy.

Highlights 

Valuation

– Enterprise Value
– CrispIdea Forecast
– Economic Value Added Analysis
– Discounted Cash Flow Analysis
– P/E Analysis
– Peer Valuation
– CrispIdea Forecast Relative to Consensus
– Consensus History and Surprise
– Consensus Momentum

Actual & Historical Performance

– Income Statement
– Balance Sheet
– Cash Flow
– 10 Year Historical Performance
– Ratio Analysis
– Du Pont Analysis
– ROIC & ROCE Analysis
– Segment Performance
– Key Metrics
– M&A Deals

Peer Performance

– Summary
– Profitability
– Growth
– Price Performance

Ownership

Stock Price Performance

No of Pages : 34